IP Verse

New Use Of An Anti-Cd303 Transmembrane Protein Antibody

Patent No. EP3390452 (titled "New Use Of An Anti-Cd303 Transmembrane Protein Antibody") was filed by Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Dec 16, 2016. The application was issued on May 26, 2021.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
STRAWMAN	Feb 28, 2022	VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

May 4, 2023
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 4, 2023
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Apr 28, 2023
Termination of the opposition proceedings with revocation of patent
Jan 19, 2023
Advice of delivery
Jan 19, 2023
Decision of the Opposition Division and instruction
Jan 19, 2023
Decision revoking the European patent
Jan 19, 2023
Decision revoking the European patent
Jan 19, 2023
Grounds for the decision (Annex) - opposition
Jan 19, 2023
Means of redress
Jan 19, 2023
Scanned annex to a communication - opposition procedure
Jan 19, 2023
Transmittal of decision / summons - opposition
Jan 19, 2023
Transmittal of decision / summons - opposition
Mar 29, 2022
Communication of a notice of opposition and request to file observations
Mar 29, 2022
Notice of further oppositions to opponent(s)
Mar 4, 2022
Communication of a notice of opposition - first information to patent proprietor
Feb 28, 2022
(Electronic) Receipt
Feb 28, 2022
Authorisation
Feb 28, 2022
Citation in opposition procedure
Feb 28, 2022
Citation in opposition procedure - 001
Feb 28, 2022
Citation in opposition procedure - 002
Feb 28, 2022
Citation in opposition procedure - 003
Feb 28, 2022
Citation in opposition procedure - 004
Feb 28, 2022
Citation in opposition procedure - 005
Feb 28, 2022
Citation in opposition procedure - 006
Feb 28, 2022
Citation in opposition procedure - 007
Feb 28, 2022
Citation in opposition procedure - 008
Feb 28, 2022
Citation in opposition procedure - 009
Feb 28, 2022
Citation in opposition procedure - 010
Feb 28, 2022
Citation in opposition procedure - 011
Feb 28, 2022
Citation in opposition procedure - 012
Feb 28, 2022
Citation in opposition procedure - 013
Feb 28, 2022
Citation in opposition procedure - 014
Feb 28, 2022
Citation in opposition procedure - 015
Feb 28, 2022
Citation in opposition procedure - 016
Feb 28, 2022
Citation in opposition procedure - 017
Feb 28, 2022
Citation in opposition procedure - 018
Feb 28, 2022
Citation in opposition procedure - 019
Feb 28, 2022
Citation in opposition procedure - 020
Feb 28, 2022
Citation in opposition procedure - 021
Feb 28, 2022
Citation in opposition procedure - 022
Feb 28, 2022
Citation in opposition procedure - 023
Feb 28, 2022
Citation in opposition procedure - 024
Feb 28, 2022
Consolidated list of cited opposition documents
Feb 28, 2022
Notice of opposition
Feb 28, 2022
Notice of opposition
Feb 28, 2022
Priority document
Jun 9, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Apr 30, 2021
Decision to grant a European patent
Apr 21, 2021
Decision to allow further processing
Apr 14, 2021
(Electronic) Receipt
Apr 14, 2021
English translation of the claims
Apr 14, 2021
German translation of the claims
Apr 14, 2021
Letter accompanying subsequently filed items
Apr 14, 2021
Request for further processing
Feb 15, 2021
Application deemed to be withdrawn ( translations of claims/payment missing)
Sep 17, 2020
Bibliographic data of the European patent application
Sep 17, 2020
Communication about intention to grant a European patent
Sep 17, 2020
Intention to grant (signatures)
Sep 17, 2020
Text intended for grant (clean copy)
Sep 17, 2020
Text intended for grant (sequence listing)
Sep 17, 2020
Text intended for grant (version for approval)
Jun 8, 2020
Communication confirming withdrawal from representation
Jun 8, 2020
Communication of amended entries concerning the representative
Jun 2, 2020
(Electronic) Receipt
Jun 2, 2020
Letter accompanying subsequently filed items
Jun 2, 2020
Submission concerning change of applicant's representative
Apr 16, 2020
(Electronic) Receipt
Apr 16, 2020
Amended description with annotations
Apr 16, 2020
Description
Apr 16, 2020
Letter accompanying subsequently filed items
Apr 16, 2020
Reply to communication from the Examining Division
Feb 14, 2020
Annex to the communication
Feb 14, 2020
Communication from the Examining Division
Oct 3, 2019
(Electronic) Receipt
Oct 3, 2019
Amended claims with annotations
Oct 3, 2019
Claims
Oct 3, 2019
Letter accompanying subsequently filed items
Oct 3, 2019
Reply to communication from the Examining Division
Jul 31, 2019
Grant of extension of time limit (examination procedure)
Jul 25, 2019
(Electronic) Receipt
Jul 25, 2019
Letter accompanying subsequently filed items
Jul 25, 2019
Request for extension of time limit to communication from the Examining Division
Apr 26, 2019
Annex to the communication
Apr 26, 2019
Communication from the Examining Division
Apr 18, 2019
Examination started
Sep 26, 2018
Notification on forthcoming publication of bibliographic data
Jul 24, 2018
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Jul 20, 2018
Communication to designated inventor
Jul 20, 2018
Communication to designated inventor
Jul 17, 2018
Priority search results copy provided by EPO
Jul 4, 2018
Copy of the international preliminary report on patentability
May 31, 2018
(Electronic) Receipt
May 31, 2018
Amended claims filed after receipt of (European) search report
May 31, 2018
Amended claims with annotations
May 31, 2018
Request for entry into the European phase
Apr 30, 2018
Information on entry into European phase
Jul 10, 2017
Priority document (electronically transmitted)
Jun 22, 2017
Converted Sequence Listing
Jun 22, 2017
Copy of the international search report
Jun 22, 2017
Copy of the international search report
Jun 22, 2017
Published international application - A1
Jun 20, 2017
Notification of the recording of a change
May 15, 2017
Notification of the recording of a change
Apr 14, 2017
Submission concerning representation
Mar 17, 2017
ISR: cited documents
Mar 17, 2017
International Search Report - copy in English for the IB
Mar 15, 2017
Written opinion of the ISA, boxes No. I to VIII
Mar 15, 2017
Written opinion of the ISA, cover sheet
Mar 15, 2017
Written opinion of the ISA, supplemental box
Feb 16, 2017
Incoming letter related to ISA procedure
Feb 16, 2017
Notification Concerning Documents Transmitted (copy for ISA/EP)
Feb 16, 2017
Submission concerning representation
Jan 31, 2017
Communication in cases for which no other form is applicable
Jan 31, 2017
Notification of receipt of Search copy
Jan 19, 2017
Incoming letter related to ISA procedure
Jan 19, 2017
Notification Concerning Documents Transmitted (copy for ISA/EP)
Jan 19, 2017
Request form for international application (copy for ISA/EP)
Jan 19, 2017
Substitute sheet (Rule 26) - request form for ISA/EP
Dec 16, 2016
Abstract
Dec 16, 2016
Claims
Dec 16, 2016
Description
Dec 16, 2016
Drawings

EP3390452

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Application Number: EP16826758A
Filing Date: Dec 16, 2016
Status: Revoked; May 5, 2023
Publication Date: May 26, 2021
External Links: Slate, Register , Google Patents